HIT BSI: Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo

Sponsor
Institute of Tropical Medicine, Belgium (Other)
Overall Status
Recruiting
CT.gov ID
NCT04289688
Collaborator
KU Leuven (Other), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo (Other), Fund for Scientific Research, Flanders, Belgium (Other), Hôpital Saint-Luc, Kisantu, République Démocratique du Congo (Other)
1,000
1
17.9
55.8

Study Details

Study Description

Brief Summary

Bloodstream infections are frequent in children admitted to the hospital for severe febrile illness in sub-Saharan Africa.Ongoing blood culture surveillance at Kisantu Hospital showed non-typhoidal Salmonella (NTS) as the first cause of bloodstream infections in children. Bloodstream infections have a high case fatality (15 - 20%). Outcome of bloodstream infections is dependent on timely diagnosis and treatment. However, observations at Kisantu Hospital showed that many children arrive late and die early after admission.

By interviewing caregivers of severely ill children admitted to Kisantu Hospital, the investigators aim to study their health itinerary, i.e. the sequence of all actions of health care seeking and care provision between the onset of febrile illness and the admission at the hospital. The investigators aim to assess the health itinerary according to the "three delays" model. The three delays model studies delays and practices at the level of health care seeking, of transport and of start of antibiotic treatment.10 Visits to referring health centers will provide complementary information about diagnosis, treatment and referral practices. In hospital follow-up will allow to assess the outcome according to the duration of health itinerary. The results of routine laboratory tests upon hospital admission will allow to stratify the health itinerary according to fever etiology.

The results of this study will allow to understand the duration of the health itinerary, its possible association with case-fatality, and factors explaining for delays at every level. This information is expected to orient local health policy makers towards interventions shortening the duration of the health itinerary and in that case improve and monitor the referral system. In addition, the study results are expected to orient towards further research to understand health seeking behavior (i.e. focus-group discussions and community-based studies).

Detailed Description

The study is designed as a hospital-based cohort study at the pediatric ward of Kisantu general referral hospital. The investigators foresee a study inclusion period of 5 months. The study period is currently determined as such that it includes approximately 2 months of the dry season and 3 months of the rainy season. Seasonality is taken into account, because the rain affects the condition of the road and local disease epidemiology and can thus influence the study results. Most data will be collected retrospectively, i.e. all data on the health itinerary collected from the questionnaire and referral letter and the data from the health records in the referring health centers. Only the data from the in-hospital laboratory tests and clinical outcome will be collected prospectively.

The data from the health records at referring health centers will be consulted after termination of the five months study inclusion period to avoid any influence from the study in the patient management at health centers during the study.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo: a Cohort Study
Actual Study Start Date :
Feb 1, 2021
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Jul 31, 2022

Outcome Measures

Primary Outcome Measures

  1. Describe health itineraries based on the three delays model in hospital admitted children with suspected bloodstream infection [7 months]

  2. Assess which exposure factors variables are associated with the duration of the health itinerary in hospital admitted children with suspected bloodstream infection [7 months]

Secondary Outcome Measures

  1. Assess the association between the duration of the health itinerary and in hospital case fatality in hospital admitted children with suspected bloodstream infection [7 Months]

  2. Describe health itinerary based on the three delays model [7 months]

    Stratification will be done according to the confirmed bloodstream infection: non-typhoidal Salmonella (NTS) bloodstream infection, Plasmodium falciparum (Pf) malaria, Pf malaria and bloodstream infection Pf malaria and NTS bloodstream infection

  3. Assess which factors influence the duration of the health itinerary, stratified per diagnostic category [7 months]

    Stratification will be done according to the confirmed bloodstream infection: non-typhoidal Salmonella (NTS) bloodstream infection, Plasmodium falciparum (Pf) malaria, Pf malaria and bloodstream infection Pf malaria and NTS bloodstream infection

  4. Assess the association between the duration of the health itinerary and in hospital case fatality [7 months]

    Stratification will be done according to the confirmed bloodstream infection: non-typhoidal Salmonella (NTS) bloodstream infection, Plasmodium falciparum (Pf) malaria, Pf malaria and bloodstream infection Pf malaria and NTS bloodstream infection

  5. Assess the diagnostic, therapeutic and referral practices at referring health centers in hospital admitted children with suspected bloodstream infection [7 months]

  6. Assess the diagnostic and therapeutic practices before hospital admission per health care provider in hospital admitted children with suspected bloodstream infection [7 months]

  7. Assess the coverage of blood cultures. [7 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Days to 5 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Be a child between 28 days and 5 years old

  • Be admitted to Kisantu Hospital

  • Have a suspected bloodstream infection, which is defined as the presence of objective fever, hypothermia or a history of fever during the past 48 hours and at least one of the following criteria: Hypotension, confusion or increased respiratory rate/Suspicion of severe localized infection: pneumonia, meningitis, osteomyelitis, complicated urinary tract infection, abscess, skin/soft tissue infection or abdominal infection/ Suspicion of typhoid fever/ Suspicion of severe malaria

  • Having a caregiver willing and able to provide written informed consent

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Saint-Luc Kisantu Kisantu Congo, The Democratic Republic of the

Sponsors and Collaborators

  • Institute of Tropical Medicine, Belgium
  • KU Leuven
  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
  • Fund for Scientific Research, Flanders, Belgium
  • Hôpital Saint-Luc, Kisantu, République Démocratique du Congo

Investigators

  • Principal Investigator: Bieke Tack, Institute of Tropical Medicine Antwerp

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institute of Tropical Medicine, Belgium
ClinicalTrials.gov Identifier:
NCT04289688
Other Study ID Numbers:
  • ITM202003
First Posted:
Feb 28, 2020
Last Update Posted:
Jul 12, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institute of Tropical Medicine, Belgium
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2022